Last reviewed · How we verify

NCT01496105

Efficacy Study of Topical Application of Lidacaine Spray Prior to IUD Insertion

Status unknown Phase 4 Last updated 20 December 2011
What this trial tests

Phase 4 trial testing Lidocaine in Drug Usage in 200 participants. Status unknown.

Timeline
1 July 2011
Primary endpoint
1 December 2011
1 January 2012

Quick facts

Lead sponsorAin Shams University
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment200
Start date1 July 2011
Primary completion1 December 2011
Estimated completion1 January 2012
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 45, female only, with Drug Usage. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The purpose of this study is to determine whether the topical use of lidocaine spray 10% on the cervix is an effective way to reduce pain during IUCD insertion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lidocaine

Trials testing the same drug.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01496105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing